Project Grant 2335845
Award Date
12/1/23
Completion Date
8/31/24
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
Biodevek Inc. (C16MAJV41YM5)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Boston, MA 02134, USA
Similar Awards
This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,250,000.00 in funding to Biodevek Inc., a small business located in Boston, MA, to develop a novel sprayable hydrogel sealant for managing gastrointestinal (GI) lesions and bleeding. The project aims to create a minimally invasive, bio-adhesive hydrogel solution that can be applied using an endoscopic delivery system to provide...
This $962,735 cooperative agreement from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084) supports the development of an enhanced biodegradable tissue adhesive for gastrointestinal surgical wound closure applications by Bezwada Biomedical LLC. The small business will refine a polyurethane-based adhesive formulation and assess its in vivo performance to identify a safe, easy-to-use lead tissue adhesive that can help prevent anastomotic...
This $275,000 federal Project Grant awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development and validation of an aerogel-based wound dressing material platform with integrated fluid management, biofilm prevention, and rapid infection detection properties. The project aims to create a novel wound dressing solution that can improve the management of chronic wounds, surgical sites, and burns by mitigating...
Karios Technologies LLC, a for-profit organization, received a $274,954 SBIR Phase I grant from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel, ready-to-use, large volume delivery system for in situ forming biomaterials. The biomaterials are intended to serve as tissue sealants, scar tissue reducers, and vehicles for drug or cell delivery during surgical procedures. The project aims to transfer a proprietary biomaterial...
This $999,783 Phase II Small Business Innovation Research (SBIR) cooperative agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports Intact Therapeutics' development of a thermogel-based drug delivery platform for the treatment of upper gastrointestinal bleeding (UGIB). Intact Therapeutics' proprietary thermogel technology aims to rapidly stop UGIB prior to endoscopic treatment, potentially reducing patient morbidity,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under CFDA Program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, provides $1,955,984 to Biodevek Inc. to develop GastroShield, a sprayable biocompatible adhesive biomaterial for endoscopic management of gastrointestinal (GI) lesions and prevention of GI bleeding. The project aims to achieve critical pre-clinical study milestones, including scaling up manufacturing,...
This SBIR Phase I grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is for the development of an advanced wound care product to treat diabetic foot ulcers. Therapeutic Bandage Products, Inc. will receive $305,000 to develop a patented microneedle bandage that delivers three therapeutic agents to disinfect the wound, prevent biofilm formation, and activate the immune system. This innovative product has significant...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a novel pressure-sensitive bioadhesive (PSB) system for minimally invasive surgery (MIS). The $625,168 award to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, will fund the fabrication of PSBs with tunable...
This National Science Foundation Technology, Innovation, and Partnerships grant award of $250,000 provides funding from August 15, 2022 to July 31, 2024 to develop and evaluate an absorbable surgical adhesive patch to reinforce internal suture lines in the urinary tract. The University of California, Los Angeles will receive the award to create a flexible, bioabsorbable internal suture reinforcement device aimed at significantly reducing post-operative complications and readmissions for...
This National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I project aims to develop a novel, minimally invasive, bioabsorbable, steroid-eluting suture and surgical implant procedure to improve outcomes for 6 million patients suffering from rhinitis under the care of otolaryngologists. The $255,045 award, granted on September 15, 2023 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, will fund the formulation of dissolvable polymers,...